Arch Associates IV Lp Three serves as Executive at ACELRX PHARMACEUTICALS INC, where they oversee executive responsibilities. Since joining the company, Arch Associates IV Lp Three has executed 14 insider transactions totaling $9.5M, demonstrating a bullish approach to their equity position. Their most recent transaction on Nov 18, 2014 involved selling 244,600 shares valued at $3.0M.
Arch Associates IV Lp Three currently holds 557,126 shares of ACELRX PHARMACEUTICALS INC (ACRX), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Arch Associates IV Lp Three has been a net buyer of ACRX stock. They have purchased $6.4M and sold $3.1M worth of shares.
Arch Associates IV Lp Three's most recent insider trade was on Nov 18, 2014, when they sold 244,600 shares at $12.29 per share.
Get notified when new Form 4 filings are submitted
| $12.29 |
| Discretionary |
| Feb 16, 2011 | ACRX | $0 | Conversion | 857,241 | $N/A | Discretionary |
| Feb 16, 2011 | ACRX | $139.3K | Purchase | 27,863 | $5.00 | Discretionary |
| Feb 16, 2011 | ACRX | $0 | Conversion | 27,440 | $N/A | Discretionary |
| Feb 16, 2011 | ACRX | $0 | Conversion | 605 | $N/A | Discretionary |
| Feb 16, 2011 | ACRX | $0 | Conversion | 520,510 | $N/A | Discretionary |
| Feb 16, 2011 | ACRX | $0 | Conversion | 11,492 | $N/A | Discretionary |
| Feb 16, 2011 | ACRX | $6.3M | Purchase | 1,261,927 | $5.00 | Discretionary |
| Feb 16, 2011 | ACRX | $0 | Conversion | 18,928 | $N/A | Discretionary |
| Feb 16, 2011 | ACRX | $0 | Conversion | 481,465 | $N/A | Discretionary |
| Feb 16, 2011 | ACRX | $0 | Conversion | 10,630 | $N/A | Discretionary |
| Feb 16, 2011 | ACRX | $0 | Conversion | 601,335 | $N/A | Discretionary |
| Feb 16, 2011 | ACRX | $0 | Conversion | 13,277 | $N/A | Discretionary |